Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
November 27, 2011

Biotronik implants first patients with new Lumax 740 ICDs

Biotronik has implanted the first patients with its new Lumax 740 implantable cardiac defibrillator (ICD), the first such device suitable for use with MRI.

Biotronik has implanted the first patients with its new Lumax 740 implantable cardiac defibrillator (ICD), the first such device suitable for use with MRI.

The ICD possesses ProMRI technology and has a life of up to 11 years.

The company said that the new intracardiac impedance assessment technology incorporated into the Lumax HF-T device will evaluate changes in left ventricular volume and could enhance therapy for heart failure.

The Lumax 740 series is part of Biotroniks advanced tachycardia product portfolio, which comprises three ICDs, one cardiac resynchronisation therapy device and 16 leads.

Related Companies

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management